Earnings Alerts

Indofood CBP Sukses (ICBP) Earnings Decline: 9M Net Income Down 13% to 7.11T Rupiah

By October 31, 2025 No Comments
  • Indofood CBP reported a net income of 7.11 trillion rupiah for the first nine months of 2025.
  • This represents a 13% decrease in net income year-on-year compared to 8.15 trillion rupiah in the same period last year.
  • Net sales increased slightly by 1.4% year-on-year, reaching 56.27 trillion rupiah.
  • The decline in net income was primarily attributed to the depreciation of the rupiah, which led to unrealized foreign exchange losses from financing activities.
  • Core profit showed a 4% year-on-year decrease, amounting to 7.69 trillion rupiah.
  • Analysts’ recommendations include 32 buy ratings, 1 hold rating, and no sell ratings for Indofood CBP.

A look at Indofood CBP Sukses Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth4
Resilience4
Momentum2
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts utilizing the Smartkarma Smart Scores have given Indofood CBP Sukses a positive long-term outlook. With strong scores in Dividend, Growth, Resilience, and a moderate score in Value, the company is seen as a promising investment opportunity. Indofood CBP Sukses, a total food solutions company, is well-positioned in the food industry, providing a wide range of food products from raw materials to consumer goods.

Despite a lower score in Momentum, the overall analysis indicates a favorable future for Indofood CBP Sukses. Investors looking for a company with solid dividends, growth potential, and resilience in the market may find Indofood CBP Sukses an attractive choice based on the Smartkarma Smart Scores assessment.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars